JC
Schedule 13G filing
JPMORGAN CHASE & CO disclosed a 5.3% stake in REGENXBIO Inc. (RGNX)
JPMORGAN CHASE & CO reported owning 5.3% of REGENXBIO Inc. (RGNX) (3,560,915 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More RGNX insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.